| A reevaluation of the primary diagnosis of hemangiopericytoma and the clinical importance of differential diagnosis from solitary fibrous tumor of the central nervous system. | |
| | |
MedLine Citation:
|
PMID: 18922629 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: Hemangiopericytomas (HPCs) are rare neoplasms with relatively high rates of recurrence and extracranial metastasis. Though the differential diagnoses from angiomatous meningiomas and from solitary fibrous tumors (SFTs) are both important, the latter diagnosis is somewhat more important in light of the benign prognosis of SFTs and the difficulties in distinguishing SFTs from HPCs. Newly developed immunohistochemical methods reveal differences in the specific immunohistochemical features of HPCs and SFTs. To elucidate whether SFTs have been misdiagnosed as HPCs in the past, our group used recent immunohistochemical methods to re-evaluate tissues that had been originally diagnosed as HPCs. We also compared the clinical features of these cases. PATIENTS AND METHODS: Thirteen sequential cases of HPC diagnosed in Kanazawa University Hospital and Kumamoto University Hospital between 1970 and 2006 were retrospectively analyzed by immunohistochemical staining for CD34, Bcl-2, epithelial membrane antigen (EMA), vimentin, and S100 protein, and by measurement of the MIB-1 labeling index (LI). The cases were then re-evaluated and newly diagnosed based on the results of the immunohistochemical stainings. The clinical course of each case was also evaluated. RESULTS: Four of the 13 cases were newly diagnosed as SFTs and eight were reconfirmed as HPCs, based on the immunohistochemical studies for CD34, Bcl-2, and reticulin staining. One case was newly diagnosed as meningioma on the basis of a strong EMA positivity. The MIB-1 LI was less than 1% in 12 of the cases. In two cases, one case of HPC and the other of meningioma, the MIB-1 LI was relatively high, 8% and 4% respectively. All eight of the HPCs recurred, and 5 of the HPC patients died of the disease. Only one case of the SFTs recurred. CONCLUSION: Our study suggests that a relatively high percentage of the tumors diagnosed as HPCs in the past may have in fact been intracranial SFTs. Immunohistochemical examinations of CD34, Bcl-2, and reticulin stains are keys for the differential diagnosis. Given that SFTs have a considerably better prognosis than HPCs, it is important to carry out meticulous immunohistochemical examinations for the primary diagnosis. |
| | |
Authors:
|
Yutaka Hayashi; Naoyuki Uchiyama; Yasuhiko Hayashi; Mitsutoshi Nakada; Masayuki Iwato; Daisuke Kita; Ryo Higashi; Yuichi Hirota; Yutaka Kai; Jun-ichi Kuratsu; Jun-ichiro Hamada |
Related Documents
:
|
1174189 - Pulmonary and articular sporotrichosis. report of two cases. 17573569 - Occupational noise-induced hearing loss reports and tinnitus in finland. 1812769 - Preconception tort liability: recognizing a strict liability cause of action for des gr... 7341039 - Record of hospitalized acute intoxication cases: a proposed statistical-epidemiological... 18420879 - Successful resuscitation after ropivacaine and lidocaine-induced ventricular arrhythmia... 3903639 - Intussusception: indications for ultrasonography and an explanation of the doughnut and... 7796069 - Generalized nonconvulsive status epilepticus after electroconvulsive therapy. 7439239 - Incomplete interpolation caused by sinoatrial pacemaker shift. a report of two cases. 22385269 - Type i cryoglobulinemia in multiple myeloma: a rare entity. analysis of clinical and bi... |
Publication Detail:
|
Type: Journal Article Date: 2008-10-14 |
Journal Detail:
|
Title: Clinical neurology and neurosurgery Volume: 111 ISSN: 1872-6968 ISO Abbreviation: Clin Neurol Neurosurg Publication Date: 2009 Jan |
Date Detail:
|
Created Date: 2008-12-22 Completed Date: 2009-02-19 Revised Date: 2010-12-07 |
Medline Journal Info:
|
Nlm Unique ID: 7502039 Medline TA: Clin Neurol Neurosurg Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 34-8 Citation Subset: IM |
Affiliation:
|
Department of Neurosurgery, Kanazawa University Hospital, Kanazawa, Japan. yuh@ns.m.kanazawa-u.ac.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Antigens, CD34 / metabolism Central Nervous System Neoplasms / diagnosis*, metabolism Diagnosis, Differential Female Hemangiopericytoma / diagnosis*, metabolism Humans Immunohistochemistry Ki-67 Antigen / metabolism Male Meningioma / diagnosis*, metabolism Middle Aged Mucin-1 / metabolism Prognosis Proto-Oncogene Proteins c-bcl-2 / metabolism Retrospective Studies S100 Proteins / metabolism Solitary Fibrous Tumors / diagnosis*, metabolism Tumor Markers, Biological / metabolism* Vimentin / metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Antigens, CD34; 0/Ki-67 Antigen; 0/Mucin-1; 0/Proto-Oncogene Proteins c-bcl-2; 0/S100 Proteins; 0/Tumor Markers, Biological; 0/Vimentin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Assessment of verbal memory by fMRI: lateralization and functional neuroanatomy.
Next Document: Traumatic aneurysm of the occipital artery secondary to paintball injury.